Blog

The immune system protects against disease. Biointron explains its cells, proteins, and organs that coordinate powerful immune defenses.

Purification isolates antibodies for use. Biointron reviews chromatography and other techniques ensuring antibody purity and reliability.

Fc receptors bridge antibodies and immune cells. Biointron highlights their roles in immune signaling and therapeutic antibody function.

Pathogens cause disease but drive immune defense. Biointron explains their types and relevance for antibody discovery and therapeutic design.

Opsonization marks pathogens for clearance. Biointron describes how this process enhances immunity and supports antibody-based therapeutic strategies.

Neutralization blocks pathogens from infecting cells. Biointron explains this immune function and its relevance in antibody design and vaccine development.

Fully human antibody discovery is advancing rapidly. Biointron highlights five key innovations that are shaping the future of safer, more effective therapies.

Immunogenicity impacts antibody safety. Biointron explains causes, risks, and strategies to minimize immune responses in therapeutic antibodies.

Microtubule inhibitors power certain ADCs. Biointron highlights how these payloads, combined with antibodies, deliver targeted cancer therapies.

Biointron and the Chinese Antibody Society co-hosted a webinar highlighting strategies to accelerate antibody drug discovery through advanced technologies.

Rituximab marked a milestone as the first cancer antibody. Biointron reviews its approval, clinical use, and role in shaping oncology therapeutics.

Mammalian cells provide authentic expression systems. Biointron explains their role in producing therapeutic proteins and antibodies with human-like properties.